OB/GYN 1401 - OB/GYN Clinical Alert - Jan 01, 2010

Target Audience:

This activity is intended for the obstetrician and gynecologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Jeffrey T. Jensen, MD, MPH
Leon Speroff
Professor of Obstetrics and Gynecology
Vice Chair for Research
Oregon Health and Science University
Portland

Peer Reviewer
Catherine Leclair, MD
Associate Professor
Department of OB/GYN
Oregon Health and Science University
Portland

Associate Editor
John C. Hobbins, MD
Professor and Chief of Obstetrics
University of Colorado Health Sciences Center
Denver

Frank W. Ling, MD
Clinical Professor
Department of Obstetrics and Gynecology
Vanderbilt University School of Medicine
Nashville

Robert L. Coleman, MD
Professor, University of Texas
M.D. Anderson Cancer Center
Houston

Subjects:

  • USPSTF Mammography Recommendations: Seeing Through the Screen
  • Intravenous Nitroglycerin for External Cephalic Version
  • Update on Adhesions and Gynecologic Surgery
  • Anti-angiogenesis Targeting Agents in Recurrent Ovarian Cancer: Now There Are Two?

Objectives:

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women?s health

Financial Disclosure:

OB/GYN Clinical Alert’s Editor, Jeffrey T. Jensen, MD, MPH, receives research support from, is a consultant to, and serves on the speakers bureau of Bayer Healthcare/Bayer Schering; he also receives research support from Wyeth and Warner-Chilcott and is a consultant to Schering Plough. Peer Reviewer Catherine LeClair, MD, and Associate Editor John C. Hobbins, MD, and Frank W. Ling, MD, report no financial relationship to this field of study. Associate Editor Robert L. Coleman, MD, is a consultant to GlaxoSmithKline, Eli Lilly Co., Abbott Laboratories, Sanofi-Aventis, and Pfizer; and serves on the speakers bureaus for GlaxoSmithKline, Eli Lilly Co., and OrthoBiotech.

Copyright 2010 AHC Media. All rights reserved.